Hypothekarbank Lenzburg AG (HBLN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 4,200.00 |
|---|---|
| 52-week range | 3,940.00 – 4,260.00 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +8.1% / +11.8% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 14.0% |
| Worst drawdown (1 year) | -3.8% |
| Average daily value traded | 0.07M CHF |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hypothekarbank Lenzburg is a Swiss regional bank based in Lenzburg in the canton of Aargau. It offers mortgage lending, savings and deposit accounts, payment services and general banking to private individuals and small and medium-sized businesses, mainly in its home region. The bank also provides investment and wealth services and has built up digital banking offerings alongside its branch network, serving personal and corporate customers across Switzerland.
On this site Hypothekarbank Lenzburg AG appears as a stock on the SIX Swiss Exchange (Switzerland), code HBLN, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hypothekarbank Lenzburg AG (HBLN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 4,200.00 on 22 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 65 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.1% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -1.4% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 2.4% | ||
| 12-month return, skipping the last month | 8.1% | ||
| Stability (higher is calmer) | 97 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 14.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -3.8% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.07M CHF | ||
| Zero-volume days | 1.7% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +2.4% |
| 1 year | +8.1% |
| 3 years | +11.8% |
| 5 years | +13.5% |
Signals
| 50-day / 200-day average | 4,186.00 / 4,100.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 38.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Mar 2026 | CHF 120.0000 |
| 18 Mar 2025 | CHF 120.0000 |
| 19 Mar 2024 | CHF 120.0000 |
| 21 Mar 2023 | CHF 115.0000 |
| 22 Mar 2022 | CHF 115.0000 |
| 23 Mar 2021 | CHF 110.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.